fluorodeoxyglucose f18 has been researched along with Nausea in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
O'Mahony, D; Power, SP | 1 |
Chow, B; Dugdale, C; Knoll, B; Kojic, E; Yakirevich, E | 1 |
Chen, YK; Chi, KH; Chi, MS; Chung, CH; Huang, SC; Ko, HL; Lee, CY; Liao, KW; Yang, KL | 1 |
Anak, Ö; Baselga, J; Birle, D; Chen, LC; Hackl, W; Krop, I; Markman, B; Melendez Cuero, M; Mita, M; Shapiro, GI; Siu, L; Stutvoet, S; Tabernero, J | 1 |
Burger, R; Held, P; Rohlfs, AK; Römer, FW; Strutz, J; Viebahn, C; Woenckhaus, M | 1 |
Momose, T; Ohtomo, K; Takao, H | 1 |
Adler, LP; Buyyounouski, MK; Klump, WJ; Konski, A; Wu, H | 1 |
Abdel-Dayem, HM; El-Zeftawy, H; Naddaf, S | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and Nausea
Article | Year |
---|---|
Double autophagy modulators reduce 2-deoxyglucose uptake in sarcoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Blood Glucose; Drug Administration Schedule; Exanthema; Female; Fluorodeoxyglucose F18; Humans; Hydroxychloroquine; Male; Middle Aged; Nausea; Positron-Emission Tomography; Sarcoma; Sirolimus; Treatment Outcome; Tumor Burden; Young Adult | 2015 |
Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Diarrhea; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; TOR Serine-Threonine Kinases; Treatment Outcome; Young Adult | 2012 |
6 other study(ies) available for fluorodeoxyglucose f18 and Nausea
Article | Year |
---|---|
Diffuse large vessel giant cell arteritis found by
Topics: Aged; Anti-Inflammatory Agents; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Nausea; Positron Emission Tomography Computed Tomography; Prednisolone; Weight Loss | 2019 |
Prolonged pyrexia and hepatitis: Q fever.
Topics: Adult; Animals; Animals, Domestic; Biopsy; Bone Marrow; Coxiella burnetii; Disease Reservoirs; Fever of Unknown Origin; Fluorodeoxyglucose F18; Granuloma; Headache; Hepatitis; Humans; Inhalation Exposure; Liver; Male; Nausea; Positron-Emission Tomography; Q Fever; Tachycardia; Transaminases; Vomiting; Zoonoses | 2014 |
Uncommon lesions in the internal auditory canal (IAC): review of the literature and case report.
Topics: Adenocarcinoma; Brain Neoplasms; Cerebellopontine Angle; Craniotomy; Ear Canal; Ear Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Hearing Loss; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nausea; Positron-Emission Tomography; Radiopharmaceuticals; Temporal Bone; Tinnitus; Tomography, X-Ray Computed; Vomiting | 2012 |
Methionine and glucose metabolism of central neurocytoma: a PET study.
Topics: Adolescent; Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Headache; Humans; Male; Methionine; Nausea; Neurocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases | 2004 |
FDG PET imaging of signet-ring cell adenocarcinoma of the stomach.
Topics: Adult; Carcinoma, Signet Ring Cell; Feeding and Eating Disorders; Fluorodeoxyglucose F18; Humans; Male; Nausea; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2005 |
F-18 FDG gastric and anterior abdominal muscle uptake secondary to nausea and vomiting.
Topics: Adult; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Nausea; Radionuclide Imaging; Radiopharmaceuticals; Rectus Abdominis; Stomach; Vomiting | 1998 |